Updated Jul 16, 2026
LEIDEN JEFFREY M has filed 1 SEC Form 4 filing across 1 company in the last 90 days — active on both sides. Lifetime open-market purchases: $100K. Lifetime open-market sales: $28.65M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | F — Tax withholding / forfeiture | 17 | $18.00 | $306 |
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | M — Option exercise | 3.0K | — | |
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | J — Other acquisition / disposition | 28.7K | — | |
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | P — Open-market purchase | 5.0K | $20.00 | $100K |
| 2026-02-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 3.5K | $485.11 | $1.72M |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | F — Tax withholding / forfeiture | 3.0K | $483.75 | $1.43M |
| 2026-02-19 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 8.3K | $0.00 | |
| 2026-01-26 | VRTX | VERTEX PHARMACEUTICALS INC / MA | A — Grant or award | 9.0K | $0.00 | |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | M — Option exercise [10b5-1] | 1 | $91.05 | $91 |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.1K | $455.22 | $942K |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 10.4K | $453.34 | $4.70M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 15.7K | $452.20 | $7.09M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 5.8K | $451.20 | $2.62M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 5.9K | $449.84 | $2.65M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.3K | $448.78 | $1.04M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 1.2K | $447.05 | $515K |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 7.9K | $445.56 | $3.52M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 4.4K | $444.36 | $1.93M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 2.5K | $443.21 | $1.09M |
| 2025-12-05 | VRTX | VERTEX PHARMACEUTICALS INC / MA | S — Open-market sale [10b5-1] | 1.3K | $441.26 | $582K |
LEIDEN JEFFREY M is a corporate insider — currently tracked as Insider of Odyssey Therapeutics, Inc. (ODTX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($100K) and 12 open-market sales ($28.65M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LEIDEN JEFFREY M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.